Avaí Bio, Inc. AVAI
Set alert
0.09 USD -0.02 -15.00%
As of Nov 2, 3:09 PM ET
0.085 Day range 0.105
0.083 52-week range 0.80
- YTD
- -77.63%
- 1 year
- -78.09%
- Open
- 0.085
- Prev close
- 0.10
- Mkt cap
- 13.08M
- Vol
- 25.73K
- Avg vol
- 94.15K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.085
- High
- 0.105
3M chart
Signals (12)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 11, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 10, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 14, 2026 | 2 months ago |
News
- Avaí Bio and Austrianova Announce Publication in Frontiers in Aging Journal Highlighting Novel Cell Encapsulation-Based Approach to Sustained Klotho Delivery
- Avant Brands Reports Q3 2026 Results Highlighted by Positive Net Income and 51% Growth in Recreational Revenue
- Avaí Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale San Raffaele for Diabetes Cell Therapy Program
- Avaí Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion
- Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference
- Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy
- Avant Brands Completes EU GMP Audit at Flowr Facility
- Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
- Avant Brands Completes Major LED Lighting Retrofit at its 80,000 Sq Ft Flowr Facility, Delivering Significant Energy Savings & Production Gains
- Avaí Bio and Austrianova Reach Agreement for Insulin-Producing Cells with Internationally Acclaimed Partner to Advance Diabetes Therapy
Your note
Sign in to keep a note on AVAI — it syncs with the Stock Master app.